© 2024 MJH Life Sciences™ and Patient Care Online. All rights reserved.
Peggy Peck
Articles
Cryptosporidium Infection Prompts FDA Recall of Colic Remedy
September 21, 2007
ROCKVILLE, Md. -- The FDA said bottles of Baby's Bliss Gripe Water, which is marketed as a remedy for "colic, hiccups, and teething," may be contaminated with a parasite that causes severe diarrhea.
FDA Okays Nasal Spray Flu Vaccine for Younger Kids
September 20, 2007
ROCKVILLE, Md. -- The FDA has expanded the indications for FluMist, a nasal influenza vaccine, to include children ages two to five.
FDA Okays Gene Test to Identify High Risk Warfarin (Coumadin) Patients
September 19, 2007
ROCKVILLE, Md. -- The FDA has approved a genetic test to identify patients who have a higher risk of bleeding with warfarin (Coumadin).
FDA Warns of Sudden Death Risk with IV Haloperidol (Haldol)
September 18, 2007
ROCKVILLE, Md. -- The FDA has issued a safety alert warning physicians that haloperidol (Haldol) given intravenously or at higher than recommended doses may increase the risk of cardiovascular events including sudden death, QT prolongation, and Torsades de Pointes.
FDA OKs Evista for Breast Cancer Prevention in High-Risk Women
September 17, 2007
ROCKVILLE, Md. -- The FDA has approved the osteoporosis drug raloxifene (Evista) for prevention of invasive breast cancer in high-risk or osteoporotic postmenopausal women.
Deaths Linked to Drug for Breakthrough Cancer Pain Prompt Warning
September 13, 2007
ROCKVILLE, Md. -- Adverse events including deaths have been linked to Fentora, a drug for breakthrough pain in cancer patients who are opioid tolerant, according to the FDA.
FDA Wants Cancer Warning and UVA Protection Rating on Sunscreen Labels
August 23, 2007
ROCKVILLE, Md. -- The FDA called today for sunscreen labels to include a warning about skin cancer and add information about ultraviolet A (UVA) protection as well as the ultraviolet B (UVB) ratings that are now standard.
FDA Okays Risperidone for Schizophrenia and Bipolar Disorder in Kids
August 22, 2007
ROCKVILLE, Md. -- The FDA approved risperidone (Risperdal) today for schizophrenia in adolescents and for bipolar I disorder in pediatric patients as young as 10.
Medicare Buck Stops at Paying for Hospital Mistakes
August 20, 2007
WASHINGTON -- Medicare has told hospitals that they will soon be responsible on their own for the expenses that incur from many common preventable mistakes they make.
FDA Approves Once-A-Year Infusion for Osteoporosis
August 20, 2007
EAST HANOVER, N.J. -- The FDA has approved a once-yearly intravenous formulation of zoledronic acid (Reclast) for osteoporosis in postmenopausal women, Novartis announced.